广发纳斯达克生物科技人民币(001092)

动态评分: 2.62分

投资组合

报告日期 名称 比例
2023-12-31 Arcturus Therapeutics Holdings Inc 0.08%
2023-12-31 Autolus Therapeutics plc ADR 0.08%
2023-12-31 Dyne Therapeutics Inc 0.08%
2023-12-31 Editas Medicine Inc 0.08%
2023-12-31 89bio Inc 0.08%
2023-12-31 EyePoint Pharmaceuticals Inc 0.08%
2023-12-31 4D Molecular Therapeutics Inc 0.08%
2023-12-31 Maravai LifeSciences Holdings Inc-A 0.08%
2023-12-31 Prime Medicine Inc 0.08%
2023-12-31 RAPT Therapeutics Inc 0.08%
2023-12-31 Adaptive Biotechnologies Corp 0.07%
2023-12-31 ALX Oncology Holdings Inc 0.07%
2023-12-31 Anavex Life Sciences Corp 0.07%
2023-12-31 Galapagos NV ADR 0.07%
2023-12-31 亘喜生物 0.07%
2023-12-31 Icosavax Inc 0.07%
2023-12-31 OmniAb Inc 0.07%
2023-12-31 Olema Pharmaceuticals Inc 0.07%
2023-12-31 REGENXBIO Inc 0.07%
2023-12-31 Revance Therapeutics Inc 0.07%

投资模拟

公告&资料